Xin Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xin Huang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Jun Dai
Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
2 shared publications- Chen Fang
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Danfeng Xu
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
1 shared publication - Fukang Sun
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Haofei Wang
Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
1 shared publication Hongchao He
Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
1 shared publication
Latest Publications
- 6 June 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 671, 255-262
ZNF692 promote proliferation through transcriptional repression of essential genes in clear cell renal carcinoma
- 6 June 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 671, 255-262
ZNF692 promote proliferation through transcriptional repression of essential genes in clear cell renal carcinoma
- Open Access
- 1 May 2022
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (5) , 1141-1145
Lateroconal fascia suspension facilitates retroperitoneal partial nephrectomy
Lateroconal fascia suspension facilitates retroperitoneal partial nephrectomy Parehe Alimu, Jun Dai, Xin Huang, Juping Zhao
- 1 May 2022
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (5) , 1141-1145
Open AccessLateroconal fascia suspension facilitates retroperitoneal partial nephrectomy
Lateroconal fascia suspension facilitates retroperitoneal partial nephrectomy Parehe Alimu, Jun Dai, Xin Huang, Juping Zhao
- RetractedOpen Access
- 8 April 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-14
RETRACTED ARTICLE: The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype
Background: Circular RNAs (circRNAs) modulate gene expression in various malignancies. However, their roles in the occurrence of bladder cancer (BC) and their underlying mechanisms of action are currently unclear. Methods: We measured levels of the circRNA phenylalanyl-tRNA synthetase subunit alpha (circFARSA) and target microRNAs (miRNAs/miRs) in BC tissues and cell lines using quantitative polymerase chain reactions. The functions of circFARSA in tumor formation were examined in mice with BC xenografts in vivo and in BC cells via determination of their proliferation, activity, apoptosis, metastasis, and invasion in vitro using cell counting kit-8 assays, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, flow cytometry, western blotting, Transwell assays, and cell wound healing assays. Interactions between miR-330 and circFARSA were predicted and confirmed by bioinformatic processing and dual-luciferase reporter gene assays, respectively. Expression profiles of miR-330 targets in BC cells were assessed via western blotting. Results: circFARSA expression was markedly upregulated in BC tissues and cell lines compared with that in normal bladder samples. Silencing circFARSA expression decreased BC cell proliferation, invasion, and migration but induced their apoptosis in vitro. Downregulating circFARSA expression slowed tumor growth in vivo and directly sponged miR-330 and inhibited its function in BC cells in vitro. Inhibiting miR-330 expression abolished the regulatory effects of circFARSA silencing on the tumor phenotypes of BC cells. Conclusions: circFARSA expression is upregulated and exerts oncogenic functions in BC by sponging miR-330.
- 8 April 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-14
RetractedOpen AccessRETRACTED ARTICLE: The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype
Background: Circular RNAs (circRNAs) modulate gene expression in various malignancies. However, their roles in the occurrence of bladder cancer (BC) and their underlying mechanisms of action are currently unclear. Methods: We measured levels of the circRNA phenylalanyl-tRNA synthetase subunit alpha (circFARSA) and target microRNAs (miRNAs/miRs) in BC tissues and cell lines using quantitative polymerase chain reactions. The functions of circFARSA in tumor formation were examined in mice with BC xenografts in vivo and in BC cells via determination of their proliferation, activity, apoptosis, metastasis, and invasion in vitro using cell counting kit-8 assays, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, flow cytometry, western blotting, Transwell assays, and cell wound healing assays. Interactions between miR-330 and circFARSA were predicted and confirmed by bioinformatic processing and dual-luciferase reporter gene assays, respectively. Expression profiles of miR-330 targets in BC cells were assessed via western blotting. Results: circFARSA expression was markedly upregulated in BC tissues and cell lines compared with that in normal bladder samples. Silencing circFARSA expression decreased BC cell proliferation, invasion, and migration but induced their apoptosis in vitro. Downregulating circFARSA expression slowed tumor growth in vivo and directly sponged miR-330 and inhibited its function in BC cells in vitro. Inhibiting miR-330 expression abolished the regulatory effects of circFARSA silencing on the tumor phenotypes of BC cells. Conclusions: circFARSA expression is upregulated and exerts oncogenic functions in BC by sponging miR-330.